Skip to content
Delayed ~15 min

EWTX EDGEWISE THERAPEUTICS

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: not announced yet

What 16 analyst firms say about EDGEWISE THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works

45.04 USD+6.17 (+15.87%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+13.9%to the avg target 51.31 USD+6.27 USD
Buy 12 · Hold 2 · Sell 0

14 rated views · 17 analyst/firm records · 16 firms

Latest report12 Oct 2026avg report date 13 Jul
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8061
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8076

Recent analyst activity · last 90 days

Our tracked history has 10 reports on EWTX from 8 analyst firms in the last 90 days (16 firms in the past year).

Comparing each firm's latest target with its previous one: 3 raised their price target, 1 lowered it, 1 left it unchanged and 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Wedbush lowered its target from $52.00 (set 2 Jun 2026) to $51.00 on 5 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Evercore ISICory KasimovBuy17 Jul 202655.00 USD
Goldman SachsPaul ChoiHold11 Aug 202636.00 USD
GuggenheimDebjit ChattopadhyayBuy6 Jul 202651.00 USD
H.C. WainwrightLander Egaña GorroñoBuy14 Oct 2026—
H.C. WainwrightLander Egana-GorronoBuy21 Sep 202657.00 USD
JPMorganTessa RomeroBuy20 Aug 202660.00 USD
Leerink PartnersJoseph P SchwartzConflictConflicting reports · excluded16 Jun 202652.00 USD
OppenheimerMazahir AlimohamedBuy9 Jul 202651.00 USD
Piper SandlerYasmeen RahimiBuy12 Oct 202651.00 USD
Raymond JamesMartin AusterBuy1 Jun 202666.00 USD
RBC Capital MarketsLeonid TimashevBuy23 Sep 202659.00 USD
StifelJames Condulis—26 Feb 202625.00 USD
TruistSrikripa DevarakondaBuy3 Jun 202652.00 USD
WedbushLaura ChicoBuy1 Jun 202652.00 USD
Weiss RatingsUnnamed analyst—15 Oct 2026—
William BlairAlethia YoungBuy16 Oct 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 02:47 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.